Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Repeat Raxibacumab in Healthy Subjects
NCT02016963Phase 3Completed
- Sponsor
- Human Genome Sciences
- Start
- Jan 2008
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
A Phase 3 trial of Raxibacumab in inhalational anthrax, sponsored by Human Genome Sciences. Started Jan 2008; status: completed.
02
Drugs
Raxibacumab
03
Conditions
inhalational anthrax
Beyond the preview
Go deeper on NCT02016963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02016963.